Géraldine Lamblin

579 total citations
15 papers, 387 citations indexed

About

Géraldine Lamblin is a scholar working on Hepatology, Nutrition and Dietetics and Surgery. According to data from OpenAlex, Géraldine Lamblin has authored 15 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 5 papers in Nutrition and Dietetics and 4 papers in Surgery. Recurrent topics in Géraldine Lamblin's work include Liver Disease and Transplantation (5 papers), Vitamin K Research Studies (4 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Géraldine Lamblin is often cited by papers focused on Liver Disease and Transplantation (5 papers), Vitamin K Research Studies (4 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Géraldine Lamblin collaborates with scholars based in France, United States and Switzerland. Géraldine Lamblin's co-authors include Armand Abergel, L. Cassagnes, Yves Boirie‌, Audrey Coilly, Thomas Sinegre, Aurélien Lebreton, Anne E. Boyer, Valérie Sautou, Philip Chennell and Thomas Lecompte and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and Nutrients.

In The Last Decade

Géraldine Lamblin

15 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Géraldine Lamblin France 10 222 179 90 82 43 15 387
Rasha Elzehery Egypt 13 169 0.8× 272 1.5× 152 1.7× 43 0.5× 29 0.7× 43 493
Kiyotaka Kurose Japan 11 204 0.9× 251 1.4× 67 0.7× 52 0.6× 27 0.6× 18 470
Haruki Uojima Japan 12 229 1.0× 203 1.1× 82 0.9× 104 1.3× 19 0.4× 71 448
Naoki Kawagishi Japan 12 248 1.1× 213 1.2× 90 1.0× 74 0.9× 22 0.5× 41 434
Tomomi Okubo Japan 13 190 0.9× 238 1.3× 46 0.5× 56 0.7× 27 0.6× 39 364
Ilaria Serio Italy 9 366 1.6× 570 3.2× 80 0.9× 64 0.8× 26 0.6× 21 750
Moreshwar S. Desai United States 14 276 1.2× 227 1.3× 285 3.2× 45 0.5× 33 0.8× 38 663
И. Г. Бакулин Russia 10 136 0.6× 223 1.2× 95 1.1× 19 0.2× 56 1.3× 124 472
Gabriela Perdomo Coral Brazil 16 446 2.0× 571 3.2× 120 1.3× 85 1.0× 66 1.5× 55 756
Kessarin Thanapirom Thailand 14 188 0.8× 232 1.3× 141 1.6× 24 0.3× 45 1.0× 64 504

Countries citing papers authored by Géraldine Lamblin

Since Specialization
Citations

This map shows the geographic impact of Géraldine Lamblin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Géraldine Lamblin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Géraldine Lamblin more than expected).

Fields of papers citing papers by Géraldine Lamblin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Géraldine Lamblin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Géraldine Lamblin. The network helps show where Géraldine Lamblin may publish in the future.

Co-authorship network of co-authors of Géraldine Lamblin

This figure shows the co-authorship network connecting the top 25 collaborators of Géraldine Lamblin. A scholar is included among the top collaborators of Géraldine Lamblin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Géraldine Lamblin. Géraldine Lamblin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Sinegre, Thomas, Thomas Lecompte, Géraldine Lamblin, et al.. (2023). Intraindividual variability over time of thrombin generation in patients with cirrhosis. Journal of Thrombosis and Haemostasis. 21(6). 1441–1452. 7 indexed citations
2.
Boirie‌, Yves, et al.. (2020). Assessment of Malnutrition, Sarcopenia and Frailty in Patients with Cirrhosis: Which Tools Should We Use in Clinical Practice?. Nutrients. 12(1). 186–186. 94 indexed citations
3.
Dharancy, Sébastien, Marie‐Noëlle Hilleret, Stéphanie Faure, et al.. (2019). Natural History of Recurrent Alcohol‐Related Cirrhosis After Liver Transplantation: Fast and Furious. Liver Transplantation. 26(1). 25–33. 25 indexed citations
4.
Sinegre, Thomas, et al.. (2018). Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis. Journal of Thrombosis and Haemostasis. 16(6). 1132–1140. 58 indexed citations
5.
Altwegg, Romain, David Laharie, Victor de Lédinghen, et al.. (2018). Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series. Digestive and Liver Disease. 50(7). 668–674. 23 indexed citations
6.
Laurent, Lucie, Claire Lemaitre, Anne Minello, et al.. (2017). Cholangiopathy in critically ill patients surviving beyond the intensive care period: a multicentre survey in liver units. Alimentary Pharmacology & Therapeutics. 46(11-12). 1070–1076. 24 indexed citations
7.
Morvan, Daniel, Juliette Joubert‐Zakeyh, Bruno Pereira, et al.. (2017). Specificities of Human Hepatocellular Carcinoma Developed on Non-Alcoholic Fatty Liver Disease in Absence of Cirrhosis Revealed by Tissue Extracts 1H-NMR Spectroscopy. Metabolites. 7(4). 49–49. 24 indexed citations
8.
Lebreton, Aurélien, et al.. (2017). Low sensitivity to thrombomodulin in patients with cirrhosis; Impact of factor VIII increase and protein C deficiency. Journal of Hepatology. 66(1). S143–S144. 1 indexed citations
9.
Lebreton, Aurélien, et al.. (2016). Plasma hypercoagulability in the presence of thrombomodulin but not of activated protein C in patients with cirrhosis. Journal of Gastroenterology and Hepatology. 32(4). 916–924. 22 indexed citations
10.
Boyer, Anne E., et al.. (2016). Managing drug–drug interactions with new direct‐acting antiviral agents in chronic hepatitis C. British Journal of Clinical Pharmacology. 83(2). 269–293. 61 indexed citations
11.
Sinegre, Thomas, et al.. (2016). Low sensibility to the action of thrombomodulin in cirrhotic patients Interest of thrombinography. Annales de biologie clinique. 74(2). 203–212. 1 indexed citations
12.
Altwegg, Romain, David Laharie, Victor de Lédinghen, et al.. (2015). Tu1345 Efficacy and Safety of Anti-TNF Therapy for Inflammatory Bowel Disease (IBD) in Liver Transplant Recipients for Primary Sclerosing Cholangitis (PSC): A Multicenter Experience. Gastroenterology. 148(4). S–865. 2 indexed citations
13.
Lamblin, Géraldine, et al.. (2014). Drug interactions and protease inhibitors used in the treatment of hepatitis C: How to manage?. European Journal of Clinical Pharmacology. 70(7). 775–789. 10 indexed citations
14.
Vallin, Mélanie, Nathalie Stürm, Géraldine Lamblin, et al.. (2013). Unrecognized intrahepatic cholangiocarcinoma: an analysis of 993 adult cirrhotic liver explants. Clinical Transplantation. 27(3). 403–409. 28 indexed citations
15.
Watine, Joseph, et al.. (1995). In vivopefloxacin-resistantCampylobacter fetusresponsible for gastro-intestinal infection and bacteremia associated with arthritis of the hip. Yonsei Medical Journal. 36(2). 202–202. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026